BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3235701)

  • 1. Hydroxydesipramine in the elderly.
    Nelson JC; Atillasoy E; Mazure C; Jatlow PI
    J Clin Psychopharmacol; 1988 Dec; 8(6):428-33. PubMed ID: 3235701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine.
    Wilens TE; Biederman J; Baldessarini RJ; Puopolo PR; Flood JG
    J Am Acad Child Adolesc Psychiatry; 1992 Jul; 31(4):691-8. PubMed ID: 1644733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Hydroxydesipramine and desipramine plasma levels and electrocardiographic effects in depressed younger adults.
    Stern SL; Ribner HS; Cooper TB; Nelson LD; Johnson MH; Suckow RF
    J Clin Psychopharmacol; 1991 Apr; 11(2):93-8. PubMed ID: 2056147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant activity of 2-hydroxydesipramine.
    Nelson JC; Mazure C; Jatlow PI
    Clin Pharmacol Ther; 1988 Sep; 44(3):283-8. PubMed ID: 3416551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
    Cooke RG; Warsh JJ; Stancer HC; Reed KL; Persad E
    Clin Pharmacol Ther; 1984 Sep; 36(3):343-9. PubMed ID: 6467794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine.
    Wilens TE; Biederman J; Baldessarini RJ; Puopolo PR; Flood JG
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):798-804. PubMed ID: 8340301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
    Sutfin TA; Perini GI; Molnar G; Jusko WJ
    J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered hydroxydesipramine concentrations in elderly depressed patients.
    Kitanaka I; Ross RJ; Cutler NR; Zavadil AP; Potter WZ
    Clin Pharmacol Ther; 1982 Jan; 31(1):51-5. PubMed ID: 7053304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of 2-hydroxydesipramine plasma concentrations.
    Nelson JC; Bock JL; Jatlow PI
    Clin Pharmacol Ther; 1983 Feb; 33(2):183-9. PubMed ID: 6822031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response?
    Stern SL; Cooper TB; Nelson LD; Johnson MH; Suckow RF
    Int Clin Psychopharmacol; 1996 Dec; 11(4):219-27. PubMed ID: 9031987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible nonlinear pharmacokinetics of desipramine after once daily dosing.
    Amsterdam JD; Brunswick DJ; Potter L; Rickels K
    Pharmacopsychiatry; 1986 Mar; 19(2):84-7. PubMed ID: 3703927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of nefazodone and desipramine: a pharmacokinetic interaction study.
    Khan AY; Preskorn SH; Horst WD
    J Pak Med Assoc; 2007 May; 57(5):230-5. PubMed ID: 17571477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse.
    Kosten TR; Gawin FH; Morgan C; Nelson JC; Jatlow P
    Am J Drug Alcohol Abuse; 1990; 16(3-4):329-36. PubMed ID: 2288330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desipramine treatment of major depression in patients over 75 years of age.
    Nelson JC; Mazure CM; Jatlow PI
    J Clin Psychopharmacol; 1995 Apr; 15(2):99-105. PubMed ID: 7782495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.
    Spina E; Gitto C; Avenoso A; Campo GM; Caputi AP; Perucca E
    Eur J Clin Pharmacol; 1997; 51(5):395-8. PubMed ID: 9049581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desipramine and 2-hydroxydesipramine plasma levels in endogenous depressed patients. Lack of correlation with therapeutic response.
    Amsterdam JD; Brunswick DJ; Potter L; Winokur A; Rickels K
    Arch Gen Psychiatry; 1985 Apr; 42(4):361-4. PubMed ID: 3977553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
    Spina E; Arena A; Pisani F
    Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonlinear desipramine kinetics: prevalence and importance.
    Nelson JC; Jatlow PI
    Clin Pharmacol Ther; 1987 Jun; 41(6):666-70. PubMed ID: 3581650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative plasma levels of doxepin and desipramine in the elderly.
    Gosselin C; Ancill RJ
    Can J Psychiatry; 1989 Dec; 34(9):921, 923-4. PubMed ID: 2611758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.